首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1674118

组织工程市场：依植入物类型、依材料类型、依应用、按地区

Tissue Engineering Market, By Graft Type, By Material Type, By Application, By Geography

出版日期: 2025年02月14日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球组织工程市场规模预计为 130.2 亿美元，预计到 2032 年将达到 289.7 亿美元，2025 年至 2032 年的复合年增长率为 12.1%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	130.2亿美元
效能资料	2020-2024	预测期	2025-2032
预测期：2025 年至 2032 年复合年增长率	12.10％	2032 年金额预测	289.7亿美元

数字。组织工程市场区域份额（%）（2025 年）

组织工程是一门跨学科领域，它应用工程和生命科学原理来开发生物替代品以恢復、维持和改善组织功能。该方法涉及将人体细胞接种到一种称为支架的生物惰性材料上，以支持新组织的生长。组织工程市场涉及用于修復或替换受损组织和器官的各种产品的研究、开发和製造。慢性病发病率上升、患有肌肉骨骼疾病的老年人数量不断增加以及技术进步是推动该市场需求的主要因素。然而，组织工程产品的高成本以及使用生物材料和干细胞的伦理问题限制了市场扩张。

市场动态

全球组织工程市场受到癌症和心血管疾病等慢性疾病日益普及的推动，对组织替代疗法的需求很高。全球老龄人口快速增加，易罹患整形外科疾病，也是主要的市场驱动力之一。根据世界卫生组织（WHO）的数据，2015年至2050年期间全球60岁及以上人口比例将几乎翻一番，从12％增加到22％。此外，再生医学领域的持续技术进步使得利用干细胞、生物分解性支架和基因治疗技术开发新型组织工程产品成为可能。这扩大了组织工程治疗的应用范围。然而，组织工程程序和生物材料加工的高成本以及与干细胞研究相关的监管问题是该市场的主要障碍。此外，缺乏执行复杂组织工程程序的熟练专业人员也对市场成长构成了挑战。目前正在进行的研究和开发重点是降低支架生物材料的製造成本，而个人化医疗方法的采用为相关人员带来了丰厚的机会。

研究的主要特点

本报告对全球组织工程市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球组织工程市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。
主要企业包括 Acelity LP Inc.、AbbVie Inc.、B. Braun SE、BioMimetic Therapeutics、Bio Tissue Technologies、CR Bard、International Stem Cell、Integra Lifesciences、Organogenesis Inc.、Osiris Therapeutics、RTI surgical, Inc.、Tissue Regenimmer Plc.。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、产品类型升级、市场扩张和行销策略做出明智的决策。
全球组织工程市场迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
透过全球组织工程市场分析中使用的各种策略矩阵，相关人员可以更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 13.02 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.10%	2032 Value Projection:	USD 28.97 Bn

Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences towards developing biological substitutes to restore, maintain, or improve tissue function. It involves seeding human cells onto biologically inert materials called scaffolds that can support new tissue growth. The tissue engineering market involves the research, development, and manufacturing of various products used for repairing or replacing damaged tissues and organs. Rising prevalence of chronic diseases, growth in geriatric population suffering from musculoskeletal disorders, and technological advancements are the major factors fueling demand in this market. However, high costs associated with tissue engineering products and ethical issues related to the use of biomaterials and stem cells limits market expansion.

Market Dynamics:

The global tissue engineering market is driven by the increasing incidence of chronic diseases such as cancer and cardiovascular diseases that generate high demand for tissue replacement therapies. Rapid growth in geriatric population worldwide who are highly prone to orthopedic conditions is another key market driver. According to World Health Organization, the proportion of world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. Furthermore, continuous technological advancements in the field of regenerative medicine has enabled development of novel tissue engineered products based on stem cells, biodegradable scaffolds, and gene therapy techniques. This has expanded applications of tissue engineering therapy. However, high costs of tissue engineering procedures, biomaterial processing and regulatory issues pertaining to stem cell research act as major barriers to the market. Lack of skilled professionals to perform complex tissue engineering surgeries also challenges market growth. Nonetheless, ongoing R&D focused on lowering manufacturing costs of scaffold biomaterials and adoption of personalized medicine approach presents lucrative opportunities for stakeholders.

Key Features of the Study:

This report provides an in-depth analysis of the global tissue engineering market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global tissue engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Acelity L.P. Inc., AbbVie Inc., B. Braun SE, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Tissue Regenix Group Plc., and Zimmer Biomet.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global tissue engineering market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue engineering market.

Detailed Segmentation-

By Graft Type:
- Allografts
- Autografts
- Xenografts
By Material Type:
- Synthetic
- Biological
- Others
By Application:
- Dermal
- Orthopedic
- Dental
- Neurology
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Acelity L.P. Inc.
- AbbVie Inc.
- Braun SE
- BioMimetic Therapeutics
- Bio Tissue Technologies
- C.R. Bard
- International Stem Cell
- Integra Lifesciences
- Organogenesis Inc.
- Osiris Therapeutics
- RTI surgical, Inc.
- Tissue Regenix Group Plc.
- Zimmer Biomet

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Graft Type
- Market Snapshot, By Material Type
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Tissue Engineering Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Tissue Engineering Market, By Graft Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Allografts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autografts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Xenografts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Tissue Engineering Market, By Material Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Synthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biological
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Tissue Engineering Market, By Application, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Dermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Orthopedic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dental
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Tissue Engineering Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Acelity L.P. Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- B. Braun SE
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BioMimetic Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bio Tissue Technologies
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- C. R. Bard
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- International Stem Cell
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Integra Lifesciences
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Organogenesis Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Osiris Therapeutics
- RTI surgical, Inc.
- Tissue Regenix Group Plc.
- Zimmer Biomet

10. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

组织工程市场：依植入物类型、依材料类型、依应用、按地区